Contrast-Enhanced Ultrasound for identifying circulatory complications after liver transplants in children
Corresponding Author
Alvaro Torres
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
Department of Radiology, Karolinska University Hospital, Huddinge, Sweden
Correspondence
Alvaro Torres, Huddinge, Department of Radiology, Karolinska University Hospital, Stockholm, Sweden
Email: [email protected]
Search for more papers by this authorSeppo K. Koskinen
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorHenrik Gjertsen
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
Department of Transplantation Surgery, Karolinska University Hospital, Huddinge, Sweden
Search for more papers by this authorBjörn Fischler
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
Department of Pediatrics, Karolinska University Hospital, Huddinge, Sweden
Search for more papers by this authorCorresponding Author
Alvaro Torres
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
Department of Radiology, Karolinska University Hospital, Huddinge, Sweden
Correspondence
Alvaro Torres, Huddinge, Department of Radiology, Karolinska University Hospital, Stockholm, Sweden
Email: [email protected]
Search for more papers by this authorSeppo K. Koskinen
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorHenrik Gjertsen
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
Department of Transplantation Surgery, Karolinska University Hospital, Huddinge, Sweden
Search for more papers by this authorBjörn Fischler
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
Department of Pediatrics, Karolinska University Hospital, Huddinge, Sweden
Search for more papers by this authorAbstract
Our main goal with this study was to share our off-label experience with CEUS for identifying circulatory complications after liver transplantation in children. A total of 74 CEUS examinations performed on 34 pediatric patients who underwent a liver transplant were retrospectively included. About 53% of the examinations were performed on children 2 years old or younger. About 82% of the examinations were performed within 30 days from the transplant. About 62% of patients were transplanted due to a cholestatic disease, 11% due to a metabolic disease, 8% were re-transplanted due to graft failure, and 19% was due to other conditions. BA was the most common reason for transplantation and represented 38% of patients. About 38% of the transplantations were performed with whole grafts from DD, 40% with split liver grafts, and 22% with left lateral segments from LD. For diagnosing arterial circulatory complications, the PPV was 80%. For diagnosing portal vein circulatory complications, the PPV was 66.7%. NPV was 100%. In 28% of the examinations, the examiner could not visualize the normal arterial blood flow without CEUS. CEUS is a non-invasive and safe imaging technique that seems valuable in these patients and further efforts are needed to license its use in the post-transplant setting.
REFERENCES
- 1Duffy JP, Hong JC, Farmer DG, et al. Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg. 2009; 208(5): 896-903.
- 2Rather SA, Nayeem MA, Agarwal S, Goyal N, Gupta S. Vascular complications in living donor liver transplantation at a high-volume center: Evolving protocols and trends observed over 10 years. Liver Transpl. 2017; 23(4): 457-464.
- 3Tiao GM, Alonso MH, Ryckman FC. Pediatric liver transplantation. Semin Pediatr Surg. 2006; 15(3): 218-227.
- 4Hom BK, Shrestha R, Palmer SL, et al. Prospective evaluation of vascular complications after liver transplantation: comparison of conventional and microbubble contrast-enhanced US. Radiology. 2006; 241(1): 267-274.
- 5Ma L, Lu Q, Luo Y. Vascular complications after adult living donor liver transplantation: Evaluation with ultrasonography. World J Gastroenterol. 2016; 22(4): 1617-1626.
- 6Tamsel S, Demirpolat G, Killi R, et al. Vascular complications after liver transplantation: evaluation with Doppler US. Abdom Imaging. 2007; 32(3): 339-347.
- 7Lu Q, Zhong XF, Huang ZX, et al. Role of contrast-enhanced ultrasound in decision support for diagnosis and treatment of hepatic artery thrombosis after liver transplantation. Eur J Radiol. 2012; 81(3): 338-343.
- 8Luo Y, Fan Y-T, Lu Q, Li B, Wen T-F, Zhang Z-W. CEUS: A new imaging approach for postoperative vascular complications after right-lobe LDLT. World J Gastroenterol. 2009; 15(29): 3670-3675.
- 9Ren J, Wu T, Zheng B-W, Tan Y-Y, Zheng R-Q, Chen G-H. Application of contrast-enhanced ultrasound after liver transplantation: Current status and perspectives. World J Gastroenterol. 2016; 22(4): 1607-1616.
- 10Teegen EM, Denecke T, Eisele R, Lojewski C, Neuhaus P, Chopra SS. Clinical application of modern ultrasound techniques after liver transplantation. Acta Radiol. 2016; 57(10): 1161-1170.
- 11Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013; 39(2): 187-210.
- 12 Clinical Pharmacology review for Lumason [Internet]. [cited 2018 Jan 26]. Available from: http://www.fda.gov/downloads/drugs/developmentapprovalprocess/developmentresources/ucm502146.pdf.
- 13 Scientific discussion for the approval of Sonovue [Internet]. [cited 2018 Jan 26]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000303/WC500055376.pdf.
- 14Sidhu PS, Cantisani V, Deganello A, et al. Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med. 2017; 38(01): 33-43.
- 15Rafailidis V, Deganello A, Watson T, Sidhu PS, Sellars ME. Enhancing the role of paediatric ultrasound with microbubbles: a review of intravenous applications. Br J Radiol. 2016; 90(1069): 20160556.
- 16 Pediatric transplantation - European Liver Transplant Registry - ELTR [Internet]. [cited 2018 Jan 22]. Available from: http://www.eltr.org/Pediatric-transplantation.html.
- 17Alobaidi R, Anton N, Cave D, Moez EK, Joffe AR. Predicting early outcomes of liver transplantation in young children: The EARLY study. World J Hepatol. 2018; 10(1): 62-72.
- 18Bekker J, Ploem S, De Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant. 2009; 9(4): 746-757.
- 19Piardi T, Lhuaire M, Bruno O, et al. Vascular complications following liver transplantation: A literature review of advances in 2015. World J Hepatol. 2016; 8(1): 36-57.
- 20Seda-Neto J, Antunes da Fonseca E, Pugliese R, et al. Twenty years of experience in pediatric living donor liver transplantation: focus on hepatic artery reconstruction, complications, and outcomes. Transplantation. 2016; 100(5): 1066-1072.
- 21Clevert D-A, Stickel M, Minaifar N, et al. Contrast-enhanced ultrasound in liver transplant: First results and potential for complications in the postoperative period. Clin Hemorheol Microcirc. 2009; 43(1–2): 83-94.
- 22García-Criado Á, Gilabert R, Bianchi L, et al. Impact of contrast-enhanced ultrasound in the study of hepatic artery hypoperfusion shortly after liver transplantation: contribution to the diagnosis of artery steal syndrome. Eur Radiol. 2015; 25(1): 196-202.
- 23Rennert J, Dornia C, Georgieva M, et al. Identification of early complications following liver transplantation using contrast enhanced ultrasound (CEUS). First results. J Gastrointest Liver Dis. 2012; 21(4): 407-412.
- 24Rossi S, Rosa L, Ravetta V, et al. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. Am J Roentgenol. 2006; 186(3): 763-773.
- 25Sidhu PS, Shaw AS, Ellis SM, Karani JB, Ryan SM. Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography. Eur Radiol. 2004; 14(1): 21-30.
- 26Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000; 320(7227): 79-82.
- 27Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005; 164(9): 552-558.
- 28Sachs AN, Avant D, Lee CS, Rodriguez W, Murphy MD. Pediatric Information in Drug Product Labeling. JAMA. 2012; 307(18): 1914-1915.
- 29Weda M, Hoebert J, Vervloet M, Moltó Puigmarti C. Study on off-label use of medicinal products in the European Union [Internet]. European Commission Department of Health and Food Safety; 2017 [cited 2018 Jan 25]. Available from: https://ec.europa.eu/health/sites/health/files/files/documents/2017_02_28_final_study_report_on_off-label_use_.pdf.
- 30Darge K, Papadopoulou F, Ntoulia A, et al. Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr Radiol. 2013; 43(9): 1063-1073.
- 31Ntoulia A, Anupindi SA, Darge K, Back SJ. Applications of contrast-enhanced ultrasound in the pediatric abdomen. Abdom Radiol. 2017; 4: 1-12.
- 32Piscaglia F, Nolsøe C, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications. Ultraschall Med. 2012; 33(01): 33-59.
- 33Piscaglia F, Bolondi L. The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006; 32(9): 1369-1375.
- 34Rosado E, Riccabona M. Off-Label Use of Ultrasound Contrast Agents for Intravenous Applications in Children. J Ultrasound Med. 2016; 35(3): 487-496.
- 35Torres A, Koskinen SK, Gjertsen H, Fischler B. Contrast-enhanced ultrasound using sulfur hexafluoride is safe in the pediatric setting. Acta Radiol. 2017; 58(11): 1395-1399.
- 36Brenner DJ, Elliston CD, Hall EJ, Berdon WE. Estimated risks of radiation-induced fatal cancer from pediatric CT. Am J Roentgenol. 2001; 176(2): 289-296.
- 37Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and severity of acute allergic-like reactions to IV nonionic iodinated contrast material in children. Am J Roentgenol. 2007; 188(6): 1643-1647.
- 38Karcaaltincaba M, Oguz B, Haliloglu M. Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children. Pediatr Radiol. 2009; 39(3): 382-384.
- 39Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. The Lancet. 2012; 380(9840): 499-505.
- 40Yusuf GT, Sellars ME, Deganello A, Cosgrove DO, Sidhu PS. Retrospective Analysis of the Safety and Cost Implications of Pediatric Contrast-Enhanced Ultrasound at a Single Center. Am J Roentgenol. 2016; 208(2): 446-452.